A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen

Haruka Karaushi; Masafumi Seki; Yutaka Miyawaki; Noriyuki Watanabe; Fumitaka Kamoshita; Kotaro Mitsutake

doi:10.12659/AJCR.937485

10 October 2022 : Case report Japan

A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen

Unusual or unexpected effect of treatment

Haruka Karaushi^12ABCD, Masafumi Seki^1ABCDEFG*, Yutaka Miyawaki

^13ABCD, Noriyuki Watanabe^14BCDF, Fumitaka Kamoshita^1BD, Kotaro Mitsutake^1DEFG

DOI: 10.12659/AJCR.937485

Am J Case Rep 2022; 23:e937485

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 2. Clinical course of the patient. The line graph shows the platelet counts of the patient. Smear and culture of M. tuberculosis from sputum are expressed as 2+, 1+, +, and –.

Back to the Article

A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen

Your Privacy